PRISM MarketView – Weekly Market Report – April 26, 2024 

Posted on

PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights

New York, N.Y., April 26, 2024 – PRISM MarketView – Equities were higher through the morning into midday trading as the S&P 500 and Nasdaq are set to snap their three- and four-week losing streaks. Big tech was the topic of Street-talk this week as some of the Magnificent Seven reported earnings. The reports produced mixed and opposite reactions by the Street as Tesla (TSLA) missed on earnings but traded higher due to positive takes on affordable models, gross margins, and Musk’s reiteration of the company’s commitment to AI.

Meanwhile, Meta Platforms (META) came under pressure despite beating earnings expectations. The stock plummeted as Zuckerberg raised concern for investors as he detailed the company’s planned ramp in its investment cycle to support AI and the Metaverse which is likely to bleed the company’s cash. Over 40% of the S&P 500 has now reported and key Q1 earnings beat metrics are trending above average. However, this week Q1 GDP illustrated slower than expected economic growth citing a 1.6% increase which disappointed as economists’ Q1 GDP estimates were cited at a 2.4% increase. This GDP miss and slowdown raised eyebrows as Q4 GDP had increased 3.4%. Further economic insight will be provided next week as earnings shift focus to largely consumer related names.

This Week’s Earnings

Ford Motor Co. (F) beat on Q1 EPS of $0.49 vs FactSet $0.43 but came in slightly short on quarterly revenues at $42.8Bn vs FactSet $42.9Bn. The company reaffirmed increased demand for hybrids and cited a surge in EV adoption that’s being hindered by pricing. The Street remained mostly upbeat on the announcement however, concerns remain about the critical need for profitability on the Model-E as pricing pressures could further losses. 

This morning the low-cost carrier, Southwest Airlines, Co (LUV) released disappointing earnings that missed on Q1 EPS ($0.36) vs FactSet ($0.34) and revenue $6.33B vs FactSet $6.42B. Due to Boeings aircraft delivery delays, the company anticipates major challenges for 2024 and 2025 which will impact financial performance. To mitigate this headwind and cut costs, the company intends to cease operations at four of its airports and expects to end the year with 2,000 fewer employees.

In the small cap space, National Bank Holdings Corp (NBHC) beat on Q1 EPS $0.82 vs Factset $0.76, but NII missed at $85.7M vs FactSet $86.8M. The bank expects continued growth in average balances across the platform. However, the overall earnings picture for regional banks has been more dismal. Regional banks have experienced earnings misses this season as higher interest rates, higher deposit costs and muted loan growth have been common pain points cited. 

Other notable reports included Verizon Communications, Inc. (VZ), GE Aerospace (GE), The Sherwin-Williams Co. (SHW), Boston Scientific Corp. (BSX), Hasbro Inc. (HAS), Caterpillar Inc. (CAT), JetBlue Airways (JBLU), Wabash National Corp (WNC), , and Central Pacific Financial Corp (CPF).

Next week’s earnings include The Coca-Cola Co. (KO), McDonald’s Corp (MCD), Starbucks Corp (SBUX), Mastercard, Inc. (MA), The Kraft Heinz Co. (KHC), Apple, Inc. (APPL), Oatly Group (OTLY), Olaplex Holdings, Inc. (OLPX), BRC Inc. (BRCC), Peloton Interactive, Inc. (PTON).

More Than Hype

If you’re trying to decide if it’s a phase or a trend, AI has maintained its permanency backed by Big Tech. While Magnificent Seven earnings swirl, AI’s expansive material growth theme continues. Another member of the Seven echoed this as Microsoft (MSFT) results topped Street estimates driven by AI investment. The stocks market value rose by $128Bn upon the report. Alphabet (GOOG) also supported the narrative as it cited accelerated growth across Search, YouTube and Cloud which saw increased contribution from AI.

AI Drug Discovery Predictive Oncology Leads PRISM NextGen Tech and AI Index on Ovarian Cancer Abstract Acceptance

M&A Moves: Matterport (MTTR) To Be Acquired By CoStar Group, Stock Up 176% On Report

Betting on Biotech Bargains 

In a recent Barron’s article, it was suggested that investors looking for start-ups might be overlooking microcaps. As biotechs make up a large piece of the microcap pie, the sector provides opportunity as higher rates have impacted available funding for biotechs and cash balances of Big Pharma are at record levels. However, this week the XBI has underperformed in spite of good news stories and analysts taking bets on biotech. Gilead (GILD) was upgraded to hold from reduce at HSBC, and HC Wainwright initiated coverage of Processa Pharmaceuticals (PCSA) with a buy rating and a target of $8, representing a 394% upside.

Positive Topline Results for Immutep’s Head and Neck Cancer Treatment

Palisade Bio Collaboration to Advance Precision Medicine for Ulcerative Colitis

Canna We Just Deschedule Already?

This week the Biden Administration called on the DEA to remove marijuana from Schedule I signaling a growing impatience as almost eight months have passed since the Department of Health and Human Services called for rescheduling to a Schedule III. The Democrats have pushed further and reiterated an entire descheduling. Cannabis companies echo the push in some of their recently issued public releases. In the coming weeks, investors should prepare for further news as cannabis earnings will ensue. 

Holidaze Season: Green Successes Cited by Most Cannabis Retailers On 4/20

It Takes More Than a Village to Raise a Successful Company: Village Farms (VFF) Continues to Gain National Share, up 71% YTD.

Mental Health Matters

Mental health has been in focus this week as Talkspace (TALK) announced it had entered a partnership to significantly expand its mental health offering. The PRISM Emerging Mental Health Index saw strong performances in morning trading on Friday from Vistagen (VTGN) which has risen 3.36%, Anavex Life Sciences (AVXL) which has gained 2.06%, and Alzamend Neuro (ALZN), which is up 1.93%.

Vistagen Tackles Mental Fatigue with Investigational Nasal Spray

Talkspace Expands Mental Health Offering to Additional Half Million Women

About PRISM MarketView:

Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at and follow us on Twitter.

PRISM MarketView does not provide investment advice.

Media Contact
Company Name:
 Prism MarketView
Phone: 646-863-6341

The post PRISM MarketView – Weekly Market Report – April 26, 2024  first appeared on Prism Media Wire.

Daily updates